Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Monoclonal antibody
by Most Market Reports in the Japan in 2022

The Monoclonal antibody top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Market Reports Monoclonal antibody Key Players in the Japan. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes.
#
Company Name
Region
Tech Topics
Total
1
market report: 559
2
market report: 558
3
Health care,Gene,Stem cell,
...[+2]
market report: 544
4
market report: 157
5
market report: 82
6
market report: 59
7
market report: 59
8
Medicine,Health care,Clinical trial,
...[+2]
market report: 40
9
market report: 36
10
Clinical trial,Cardiovascular agent,Drug,
...[+2]
market report: 30
11
Drug,Clinical trial,Health care,
...[+2]
market report: 28
12
market report: 27
13
Health care,Over-the-counter,Clinical trial,
...[+2]
market report: 21
14
market report: 19
15
Medicine,Health care,Toxoid,
...[+2]
market report: 12
16
market report: 11
17
Diagnostic Reagent,Medicine,Health care,
...[+2]
market report: 11
18
market report: 9
19
market report: 7
20
market report: 7
Page generation time: Jul 17 2025